Portuguese 
English 
Spanish 
5 min of reading 
0 comments 
Aché Laboratories Expands Its Presence in the Northeast with New Investment in Pernambuco. The Expansion at the Port of Suape Promises to Transform the Local Industrial Landscape and Create Thousands of Jobs by 2026
The announcement by Aché Pharmaceutical Laboratories on Wednesday (17) marks a milestone for the Brazilian pharmaceutical industry. The company revealed an investment of R$ 267 million to expand its unit at Port of Suape, in Pernambuco. The initiative aims to create 3,000 direct and indirect jobs by 2026, consolidating the state as a strategic hub for the sector.
Expansion of Aché Laboratories’ Factory at the Port of Suape
Aché Laboratories’ unit in Suape, inaugurated in 2019, is already considered one of the most modern in the country. With the new investment, the plant will be expanded with an additional area of 13,565 m², focusing on the production of sterile medications, such as hospital injectables and eye drops.
According to the company’s president, José Vicente Marino, the unit represents a point of pride for both Aché Laboratories and the state of Pernambuco, due to its direct impact on the lives of thousands of people — from the jobs it creates to the patients who will benefit from the medications produced.
-
Historic bankruptcy of Centauro shocks the market, and the century-old company puts more than 500,000 products, machines, and complete infrastructure up for online auction.
-
Abandoned house for 15 years disappears in the woods, shocks owner with unrecognizable scenery and is reborn in an intense transformation after almost 90 hours of work in just 10 days.
-
In just three hours, a natural stone floor transforms the entrance of the house with an organic effect, immediate drainage, and a sophisticated non-slip finish that doesn’t puddle water, dries quickly, and impresses with the final result.
-
‘Interlocking brick’ made of earth arrives in the construction industry with cost reductions of up to 40% on the project.
The expansion reinforces the company’s commitment to innovation and public health, in addition to strengthening Aché Laboratories’ presence in the national and international market.
Billion-Dollar Investment and Regional Economic Impact
The new investment of R$ 267 million adds to the R$ 800 million already invested in the construction and initial operation of the unit, totaling R$ 1.67 billion in investments in the state. The new stage of expansion will allow the factory to produce up to 40 million units per year of sterile medications.
This growth not only expands the company’s production capacity but also positions Pernambuco as one of the main pharmaceutical hubs in Brazil. The investment attracts attention from international markets and strengthens the local production chain.
Port of Suape: Strategic Infrastructure for the Pharmaceutical Sector
The Port of Suape has established itself as one of the main industrial and logistical complexes in the country. Its privileged location, modern infrastructure, and tax incentives make it an attractive site for large companies, such as Aché Laboratories.
The arrival of new investments reinforces the port’s vocation as a center for innovation and development. The expansion of the pharmaceutical factory contributes to strengthening the regional and national economy, in addition to generating qualified jobs and fostering scientific research.
Creation of 3,000 Jobs in Pernambuco
The forecast of 3,000 jobs by 2026 represents a significant boost for the labor market in Pernambuco. The state had already shown signs of economic recovery, with a growth of 4.9% in GDP in 2024, the largest advance in the last 15 years.
In 2024, more than 62,000 formal jobs were created, consolidating Pernambuco as one of the largest employers in the Northeast. Since the beginning of the current state administration, more than 136,000 jobs have been generated, demonstrating a favorable environment for business and investment.
The expansion of Aché Laboratories directly contributes to this landscape, offering opportunities in various areas such as production, logistics, engineering, quality control, and administration.
Aché Laboratories: A Reference in Innovation and Health
With more than five decades of operation, Aché Laboratories is one of the largest pharmaceutical companies in Brazil. The company continuously invests in research, development, and innovation, focusing on high-technology and quality medications.
The new plant in Suape will be dedicated to the production of sterile medications, which require strict safety standards and technology. This specialization reinforces the company’s position as a reference in the sector and expands its capacity to meet the demands of the national and international market.
Aché’s commitment to the health and well-being of the population is reflected in every stage of the expansion project, from job creation to access to modern and effective treatments.
Exports and Internationalization of Production
The new structure will allow medications produced in Pernambuco to be exported to demanding markets such as the United States and European countries. This represents a strategic opportunity for Brazil to expand its presence in the global pharmaceutical sector.
The internationalization of production strengthens the competitiveness of the national industry and positions Aché Laboratories as a relevant player in the global landscape. The factory in Suape will be equipped with cutting-edge technology capable of meeting the strictest international quality standards.
Infrastructure of the New Plant at the Port of Suape
The expansion work is scheduled to be completed by 2026. During this period, thousands of jobs will be created, boosting various sectors of the local economy, such as construction, logistics, services, and commerce.
The new area of 13,565 m² will be equipped with automated systems, clean rooms, and state-of-the-art equipment, ensuring the safe and efficient production of sterile medications. The plant will also feature quality control laboratories and climate-controlled storage areas.
Government Support and Business Environment in Pernambuco
The Government of Pernambuco has adopted policies aimed at attracting investments and generating jobs. The partnership with the private sector has been essential to drive economic growth and strengthen the business environment.
The expansion of Aché Laboratories is a clear example of how collaboration between government and companies can transform realities and promote sustainable development. The project has institutional and technical support to ensure its viability and success.
Additionally, the state offers tax incentives and adequate infrastructure for companies that wish to establish or expand their operations, as is the case with the industrial complex of the Port of Suape.
Economic Indicators and Projections for the Pharmaceutical Sector
- Pernambuco’s GDP grew 4.9% in 2024
- More than 62,000 formal jobs created in the same year
- 136,000 jobs generated since the beginning of the current state administration
- Total investment by Aché Laboratories in Suape: R$ 1.67 billion
- Production capacity of the new plant: up to 40 million units/year
These numbers demonstrate the growth potential of the region and the importance of initiatives such as the expansion of the factory at the Port of Suape for strengthening the Brazilian pharmaceutical industry.
Strategic Relevance for the Future of the National Industry
The announcement made in September 2025 by Aché Laboratories represents much more than a financial investment. It is a milestone for the national pharmaceutical industry, for regional development, and for thousands of families who will benefit from new job opportunities.
With R$ 267 million in investment and the creation of 3,000 jobs, the project reaffirms the strategic role of the Port of Suape as a driver of innovation and economic growth. The initiative also reinforces Aché Laboratories’ commitment to health, technology, and sustainable development, consolidating its position as a reference in the Brazilian and international pharmaceutical sector.
Seja o primeiro a reagir!